Present and future treatment of pancreatic cancer

被引：46
作者：
Heinemann, V [1 ]
机构：
[1] Univ Munich, Dept Hematol Oncol, Klinikum Grosshadern, D-81377 Munich, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.34269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 31
页数：9
相关论文
共 62 条
[1]  
ABBRUZZESE JL, 2001, P AN M AM SOC CLIN, V20, pA518
[2]  
ALABISO O, 2001, P AN M AM SOC CLIN, V20, pA2331
[3]  
ANCHISI S, 2000, P AN M AM SOC CLIN, V19, pA1280
[4]  
BERLIN J, 2001, P AN M AM SOC CLIN, V20, pA505
[5]   A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296) [J].
Berlin, JD ;
Adak, S ;
Vaughn, DJ ;
Flinker, D ;
Blaszkowsky, L ;
Harris, JE ;
Benson, AB .
ONCOLOGY, 2000, 58 (03) :215-218
[6]   Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial [J].
Bramhall, SR ;
Rosemurgy, A ;
Brown, PD ;
Bowry, C ;
Buckels, JAC .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) :3447-3455
[7]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[8]  
CAMPOS LT, 2001, P AN M AM SOC CLIN, V20, pA2315
[9]  
CAO MG, 2001, P AN M AM SOC CLIN, V20, pA2274
[10]   Phase II study of gemcitabine in patients with advanced pancreatic cancer [J].
Carmichael, J ;
Fink, U ;
Russell, RCG ;
Spittle, MF ;
Harris, AL ;
Spiessi, G ;
Blatter, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (01) :101-105
1234567